CD274 and neoplasm: PD-L1 expression of 1% or more on tumor cells occurred in 76 (28.8%) patients; PD-L1 expression of less than 1% occurred in 58 (22.0%) patients; and PD-L1 status was unknown in 130 (49.2%) patients.